Coral Olazagasti

Publication Activity (10 Years)

Years Active: 2020-2023
Publications (10 Years): 14

Top Topics

Patient Satisfaction

African American

Top Venues

Lung cancer management

Cancer control : journal of the Moffitt Cancer Center

JCO oncology practice

JCO global oncology

This page only lists publications with an associated author ORCID identifier.

Publications

Lecia V Sequist, Coral Olazagasti
Twenty-year Progress in Lung Cancer Screening: A Marathon, Not a Sprint. Radiology 309 (2) (2023)
Coral Olazagasti, Nagashree Seetharamu, Nina Kohn, David Steiger
Implementing physician education to increase lung cancer screening uptake. Lung cancer management 11 (2) (2023)
Coral Olazagasti, Narjust Florez
Going Back Home: Understanding Physician Migration to the United States. JCO global oncology 9 (2023)
Coral Olazagasti, Nagashree Seetharamu, Nina Kohn, David Steiger
Implementing physician education to increase lung cancer screening uptake. Lung cancer management 11 (2) (2023)
Coral Olazagasti, Nagashree Seetharamu
Disparities in Lung Cancer Screening in Puerto Rico: A United States Colony with Unequal Benefits. Cancer control : journal of the Moffitt Cancer Center 28 (2022)
Idalid Franco, Coral Olazagasti, Fauzia Osman, Narjust Florez
Proyecto ELEVAR: Evaluating the Latinx Experience With the Health Care System Through Variables on Access and Resources. JCO oncology practice 18 (5) (2022)
Coral Olazagasti, Matthew Ehrlich, Nina Kohn, Karen Aviles, Aldane Hoilett, Nagashree Seetharamu
Missed Opportunities? An Observational Analysis of Lung Cancer Screening Utilization Amongst Patients With Lung Cancer. Cancer control : journal of the Moffitt Cancer Center 29 (2022)
Carolina Bernabe, Ana I Velazquez, Coral Olazagasti, Cristiane Decat Bergerot, Paulo Gustavo Bergerot, José F Corona-Cruz, Ivy Riano, Christina Adaniel, Francisca Ramirez, Jesus D Anampa, Carmen Cajina, Evelin Mena, Elias Gracia, Alvaro Menendez, Henry Idrobo, Raimundo Bezares, Omar Orlando Castillo Fernandez, Liseth Duque, Luis Corrales-Rodríguez, Glenda Ramos, Alba J Kihn-Alarcón, Ilana Schlam, Ximena Jordan Bruno, Gerardo A Umanzor, Jenny Lissette Castro, Federico Losco, Luis Ubillos, Eduardo Richardet, Enrique Soto Pérez de Celis, Narjust Florez, null null
HOLA COVID-19 Study: Evaluating the Impact of Caring for Patients With COVID-19 on Cancer Care Delivery in Latin America. JCO global oncology 8 (2022)
Coral Olazagasti, Chung-Shien Lee, Angel W Liu, Dimitre Stefanov, Kit Cheng
A deep dive into CDK4/6 inhibitors: Evaluating real world toxicities and treatment paradigms in the elderly population. Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners (2021)
Richard Lewis Martin, Michael J Grant, Stephen M Kimani, Shonali Midha, Jori May, Rushad Patell, Emily Collier, David Furfaro, Charles Bodine, Leo E Reap, Nikesh N Shah, Jess DeLaune, Samuel B Brusca, Coral Olazagasti, Shreya Goyal, Samuel M Rubinstein, Nausheen Hakim, Shuai Qin, Sabrina L Browning, Laura Sena, Jill Gilbert, Mario A Davidson, Christine M Lovly, Nagashree Seetharamu, Deepa Rangachari, Martina Murphy, Monica S Chatwal, Rita Paschal, Elizabeth Henry, Frances Collichio, Jennifer R Green
Forming the Hematology-Oncology Collaborative Videoconferencing (CO-VID) Learning Initiative: Experiential Lessons Learned From a Novel Trainee-Led Multidisciplinary Virtual Learning Platform. JCO oncology practice (2021)
Coral Olazagasti, Nagashree Seetharamu
Disparities in lung cancer screening rates among the Hispanic/LatinX population. Lung cancer management 10 (3) (2021)
Coral Olazagasti, Narjust Duma
Cancer Care for All? Tales of Caring for Undocumented Patients with Cancer. The oncologist 25 (7) (2020)
Coral Olazagasti, Isabel Preeshagul, Mohamed Aziz, Nagashree Seetharamu
Optimizing Tissue Use: A Step-wise Approach to Diagnosing Squamous Cell Lung Carcinoma on Small Biopsies. Clinical pathology (Thousand Oaks, Ventura County, Calif.) 13 (2020)
Coral Olazagasti, Carolina Bernabe, Nagashree Seetharamu
Lung cancer screening guidelines are clear but are they being followed? Lung cancer management 9 (4) (2020)